Novel Vaccine Delivery Systems Market

1. Global Novel Vaccine Delivery System Market is valued at USD 5560.7 Million in 2021 and is expected to reach USD 11400.1 Million by 2028 with a CAGR of 10.8% over the forecast period. Global Novel Vaccine Delivery System Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- Increasing prevalence of infectious diseases, rising innovations in novel vaccine delivery systems and growing investments in vaccine innovation are major factors anticipated to drive the growth of Global Novel Vaccine Delivery System Market. Key Players of Global Novel Vaccine Delivery System Market- Some of the key players for global novel vaccine delivery system market are •3M •ICONOVO AB •BD •Corium Inc. •INOVIO Pharmaceuticals •Enesi Pharma •Vaxxas •Ichor Medical Systems •Debiotech S.A. •others. Global Novel Vaccine Delivery System Market Segmentation:- The global novel vaccine delivery system market is segmented into on the basis of delivery mode, device, and region & country level. On the basis of delivery mode, the novel vaccine delivery system market is segmented into intradermal, subcutaneous, intramuscular and other. On the basis device, the global novel vaccine delivery system market is segmented into syringe, needle free injection systems and others. The syringe type is further subdivided into conventional syringe and smart syringe and the smart syringe is subdivided into active safety syringes, passive safety syringes and auto disable syringes. The needle

2. free syringes systems further subdivided into spring-based injector systems, air forced injector systems and others. By Delivery Mode: •Intradermal •Subcutaneous •Intramuscular •Other By Device: •Syringe oConventional Syringe oSmart Syringe •Active Safety Syringes •Passive Safety Syringes oAuto Disable Syringes •Needle-Free Injection System •Spring-based Injector Systems •Air Forced Injector Systems •Others. News- First Needle-Less Covid vaccine Against all Variants Entered Human Trials in UK's Cambridge University On December 14th, 2021;The Jonathan Heeney at the University of Cambridge and spin- out company DIOSynVax developed a needle less next-generation coronavirus vaccine administered through a needle-free ‘injection’ that delivers it into the skin. The vaccine is air-powered and clinical trial are going on. Vaccine is said to be effective against all present COVID-19 variants and future corona viruses. The NIHR Southampton Clinical Research Facility (CRF) delivered the first trails of vaccine. The trial was carried on healthy volunteers aged between 18 and 50 in the Southampton area which had both doses of a COVID-19 vaccine, but not their booster.

3. On Special Requirement Novel Vaccine Delivery System Market Report is also available for below Regions and Country: North America •U.S. •Canada Europe •Germany •France •U.K. •Italy •Spain •Sweden •Netherland •Turkey •Switzerland •Belgium •Rest of Europe Asia-Pacific •South Korea •Japan •China •India •Australia •Philippines •Singapore •Malaysia •Thailand •Indonesia •Rest Of APAC Latin America •Mexico •Colombia •Brazil •Argentina

4. •Peru •Rest of South America Middle East and Africa •Saudi Arabia •UAE •Egypt •South Africa •Rest Of MEA Key Benefits of Global Novel Vaccine Delivery Systems Market Report- •Global Novel Vaccine Delivery Systems Market report covers in-depth historical and forecast analysis. •Global Novel Vaccine Delivery Systems Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. •Global Novel Vaccine Delivery Systems Market report helps to identify opportunities in the marketplace. •Global Novel Vaccine Delivery Systems Market report covers extensive analysis of emerging trends and competitive landscape.